Key Research Areas:
Targeted and image-guided drug delivery
Vaccine adjuvant design
Cancer immunotherapy
Photobiomodulation and nitric oxide signaling
Near-infrared fluorescence imaging
In vivo imaging and therapeutic monitoring
Physicochemical engineering of nanoparticles
mRNA and nucleic acid delivery
The NOVA Lab focuses on the development of image-guided therapeutic nanoplatforms by understanding in vivo transport mechanisms and nano–bio interactions of targeted nanotherapeutics for the delivery of hydrophobic drugs and antisense oligonucleotides. In addition, our research explores light-based photomodulation strategies and scavenger therapy approaches to regulate biological pathways and enhance therapeutic efficacy.
The NOVA Lab has developed a plasmonic nanoplatform that integrates localized surface plasmon resonance (LSPR), surface-enhanced Raman scattering (SERS), and hybrid plasmonic systems. This platform offers exceptional sensitivity, label-free detection capabilities, and strong potential for miniaturized, point-of-care diagnostics, particularly for neurodegenerative diseases such as Alzheimer’s disease.